Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity
- PMID: 26791132
- PMCID: PMC4735436
- DOI: 10.1136/bcr-2015-214093
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity
Abstract
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive haematological malignancy in the elderly, with a high frequency of cutaneous and bone marrow involvement and poor prognosis. We report a case of BPDCN with classic presentation and discuss its treatment and the value of different investigation tools used in diagnosis and response assessment.
2016 BMJ Publishing Group Ltd.
Figures





References
-
- Jacob MC, Chaperot L, Mossuz P et al. . CD4+CD56+lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 2003;88:941–55. - PubMed
-
- Bueno C, Almeida J, Lucio P et al. . Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 2004;89:58–69. - PubMed
-
- Ng AP, Lade S, Rutherford T et al. . Primary cutaneous CD4+/CD56+hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases. Haematologica 2006;91:143–4. - PubMed
-
- Chan J, Jaffe E, Ralfkiaer E. Blastic NK-cell lymphoma. In: Jaffe ES, ed.. WHO classifications of tumors of pathology genetics tumours haematopoietic. lymphoid tissues. Lyon, IARC Press, 2001:214.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical